Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CD200R1 encodes a receptor for the OX-2 membrane glycoprotein. Additionally we are shipping CD200R1 Proteins (21) and CD200R1 Kits (11) and many more products for this protein.
Showing 10 out of 284 products:
Human Polyclonal CD200R1 Primary Antibody for WB - ABIN611279
Basu, Dong, Krainer, Howe: The intracisternal A-particle proximal enhancer-binding protein activates transcription and is identical to the RNA- and DNA-binding protein p54nrb/NonO. in Molecular and cellular biology 1997
Show all 3 references for ABIN611279
Human Monoclonal CD200R1 Primary Antibody for FACS - ABIN4897040
Wong, Brenneman, Chesney, Spaner, Gorczynski: Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice. in Cancer research 2012
Human Polyclonal CD200R1 Primary Antibody for IF (p), IHC (p) - ABIN1713461
Sun, Xu, Huang, Huang, Sun, Xiao, Sun: CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma. in Immunology letters 2016
Human Polyclonal CD200R1 Primary Antibody for ELISA, WB - ABIN238589
Spinazzi, Rucinski, Neri, Malendowicz, Nussdorfer: Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells. in The Journal of clinical endocrinology and metabolism 2005
Human Monoclonal CD200R1 Primary Antibody for FACS - ABIN180787
Wright, Cherwinski, Foster-Cuevas, Brooke, Puklavec, Bigler, Song, Jenmalm, Gorman, McClanahan, Liu, Brown, Sedgwick, Phillips, Barclay: Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. in Journal of immunology (Baltimore, Md. : 1950) 2003
CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization.
Data show that neutrophil infiltration of tissues was markedly decreased in CD200 antigen (show CD200 Antibodies) (tg) transgenic animals and increased in CD200 receptor 1 CD200R1(-/-) knockout mice.
we show a causal role for the CD200 (show CD200 Antibodies)-CD200R inhibitory axis in arteriogenesis in a murine hindlimb ischemia model.
CD200 (show CD200 Antibodies)-CD200R1 interaction in glial cells is involved in the neuroprotective action of PPAR-gamma (show PPARG Antibodies) agonists.
[review] Influenza-infected CD200R1-deficient mice show less bacterial load and exhibit decreased pathogenesis and mortality than wild-type animals following streptococcal pneumonia superinfection.
Anti-CD200R2 (show CD200R1L Antibodies), anti-IL-9 (show IL9 Antibodies), anti-IL-35, or anti-TGF-beta (show TGFB1 Antibodies) abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice, and suggest combined role of mast cells and Tregs.
AML1 (show RUNX1 Antibodies)-ETO (show RUNX1T1 Antibodies) upregulated CD200R1 in lineage(-) cells, which was characteristic of AML1 (show RUNX1 Antibodies)-ETO (show RUNX1T1 Antibodies)-positive leukemia in mice.
a role for both graft and host CD200 (show CD200 Antibodies)/CD200R expression in increased allograft survival.
The main sites of CD200/CD200 (show CD200 Antibodies) receptor (CD200R) interaction in neonates and blood vessels, until adulthood, highlight the possible role of the CD200 (show CD200 Antibodies)/CD200R system in microglial development and renewal.
These data demonstrate an unanticipated and novel requirement for CD200R1 in "licensing" pro-inflammatory functions of TLR2 (show TLR2 Antibodies) and in limiting viral replication that are supported by ex vivo and in vivo evidence.
Constitutively expressed Siglec-9 (show SIGLEC9 Antibodies) inhibits LPS (show IRF6 Antibodies)-induced CCR7 (show CCR7 Antibodies), but enhances IL-4 (show IL4 Antibodies)-induced CD200R expression in human macrophages.
Inflammatory Bowel Disease patients showed a significant decrease in the percentage of plasmacytoid dendritic cells and myeloid dendritic cells expressing CD200R1 compared to that of the control group.
CD200 (show CD200 Antibodies)-CD200R1 signaling may be required for human pregnancy success.
This is the first report of CD200R1 expression by human epithelial tumor cells, and specifically, early-stage human breast cancer cells. It is also the first report of CD200R1 expression by term placental villous trophoblasts.
data show that the expression of CD200R, CD95 (show FAS Antibodies) and CD95L (show FASL Antibodies) was influenced by cardiac surgery and imply the role of these membrane molecules in cell regulation-inhibition and apoptosis following cardiac surgery.
The authors showed that the viral orthologues e127 from rat cytomegalovirus and K14 (show KRT14 Antibodies) from human herpesvirus 8 do not bind the activating CD200R-like proteins from their respective species, although they do bind the inhibitory receptors.
The proportion of CD200R1+ cells in PBMCs, peripheral CD14 (show NDUFA2 Antibodies)+ cells and CD4 (show CD4 Antibodies)+ T cells was significantly lower in rheumatoid arthritis patients compared to controls.
We demonstrate a significant correlation between CD200R1 positive cells and disease severity in rheumatoid arthritis (RA) patients, thus indicating the relevance of the CD200 (show CD200 Antibodies)/CD200R1 signaling pathway potential involvement in the pathogenesis of RA.
The mechanism underlying ESA (show FLOT2 Antibodies) might be associated with enhanced expression of CD200 (show CD200 Antibodies) and CD200R in the trophoblast, leading to an upregulation of the immune response during the first trimester of pregnancy.
The expression of CD200R as well as B7-H4 (show VTCN1 Antibodies) co-stimulatory molecules on CD14 (show NDUFA2 Antibodies)(+) cells were significantly higher in cord blood when compared with peripheral blood.
This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. Mouse studies of a related gene suggest that this interaction may control myeloid function in a tissue-specific manner. Alternative splicing of this gene results in multiple transcript variants.
CD200 receptor 1
, CD200 receptor 1-like
, CD200 cell surface glycoprotein receptor
, Orexin receptor 2
, antigen identified by monoclonal antibody MRC OX-2 receptor
, cell surface glycoprotein CD200 receptor 1
, cell surface glycoprotein OX2 receptor 1
, MOX2 receptor
, cell surface glycoprotein receptor CD200
, OX102 antigen
, OX2 receptor